Enterprise Value:
$1.64B-$93.68M(-5.41%)Summary
- As of today, RXRX enterprise value is $1.64 billion, with a fall of -$93.68 million (-5.41%) during the most recent trading session on December 19, 2025.
- Over the past year, RXRX enterprise value has dropped by -$404.37 million (-19.81%).
- RXRX enterprise value is now -74.16% below its all-time high of $6.33 billion.
Performance
RXRX Enterprise Value Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Enterprise Value Formula
Enterprise Value = Market Cap + Total Debt − Cash & Cash Equivalents
RXRX Enterprise Value Trends
| PeriodPeriod | Enterprise ValueEnterprise Value | Market CapMarket Cap | PricePrice |
|---|---|---|---|
| 1D1 Day | -5.4% | -4.0% | -4.0% |
| 1M1 Month | +7.7% | +5.5% | +5.7% |
| 3M3 Months | -3.9% | +3.4% | -13.2% |
| 6M6 Months | -1.8% | +6.7% | -16.6% |
| YTDYTD | -25.3% | -17.3% | -37.0% |
| 1Y1 Year | -19.8% | -6.8% | -30.1% |
| 5Y5 Years | - | - | - |
RXRX Enterprise Value Highs & Lows
| PeriodPeriod | HighHigh | Current vs Highvs High | LowLow | Current vs Lowvs Low | |
|---|---|---|---|---|---|
| 1M | 1-Month | $1.98B | -17.4% | $1.43B | +14.7% |
| 3M | 3-Month | $2.76B | -40.7% | $1.43B | +14.7% |
| 6M | 6-Month | $2.76B | -40.7% | $1.43B | +14.7% |
| 1Y | 1-Year | $3.88B | -57.8% | $1.20B | +36.3% |
| 3Y | 3-Year | $3.88B | -57.8% | $456M | +259.1% |
| 5Y | 5-Year | $6.33B | -74.2% | $326M | +401.4% |
| All-Time | All-Time | $6.33B | -74.2% | $326M | +401.4% |
RXRX Enterprise Value History
| Date | Value |
|---|---|
| 2025 | $1.64B(-25.3%) |
| 2024 | $2.19B(+11.7%) |
| Date | Value |
|---|---|
| 2023 | $1.96B(+101.6%) |
| 2022 | $972.60M(-59.6%) |
| 2021 | $2.41B |
FAQ
- What is Recursion Pharmaceuticals, Inc. enterprise value?
- What is the all-time high enterprise value for Recursion Pharmaceuticals, Inc.?
- What is RXRX enterprise value year-to-date change?
- What is Recursion Pharmaceuticals, Inc. enterprise value year-on-year change?
What is Recursion Pharmaceuticals, Inc. enterprise value?
The current enterprise value of RXRX is $1.64B
What is the all-time high enterprise value for Recursion Pharmaceuticals, Inc.?
Recursion Pharmaceuticals, Inc. all-time high enterprise value is $6.33B
What is RXRX enterprise value year-to-date change?
Recursion Pharmaceuticals, Inc. enterprise value has changed by -$554.93M (-25.32%) since the beginning of the year
What is Recursion Pharmaceuticals, Inc. enterprise value year-on-year change?
Over the past year, RXRX enterprise value has changed by -$404.37M (-19.81%)